CAPRICOR THERAPEUTICS, INC. Variable Lease, Cost
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Variable Lease, Cost of $358.09 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-06-30 was $358.09K, a 221.51% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-03-31 was $304.62K, a 181.73% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-06-30 was $111.38K.
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-03-31 was $108.13K.
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $879.16K, a 100.53% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $438.43K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 12 month |
|---|---|---|---|
| 2026-06-30 | $358.09K 10-Q · filed 2026-08-14 | $662.71K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $304.62K 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $879.16K 10-K · filed 2026-03-17 | ||
| 2025-06-30 | $111.38K 10-Q · filed 2026-08-14 | $219.50K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $108.13K 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $438.43K 10-K · filed 2026-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |